Showing results (1271-1280 of 1,340) with videos related to

Sort By:
Pageof 134
Cancers|February 25, 2022
Early Neutrophilia Marked by Aerobic Glycolysis Sustains Host Metabolism and Delays Cancer CachexiaMichele Petruzzelli, Miriam Ferrer, Martijn J Schuijs, et al.
Nature Communications|January 31, 2018
Isolated proton bunch acceleration by a petawatt laser pulseP Hilz, T M Ostermayr, A Huebl, et al.
Optics Letters|August 15, 2018
Energy enhancement of the target surface electron by using a 200 TW sub-picosecond laserJ Y Mao, O Rosmej, Y Ma, et al.
Brain : a Journal of Neurology|October 8, 2025
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementiaRebecca E James, Michael Bekier, Pin-Tsun Justin Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 15, 2014
Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertensionSherin Alias, Bassam Redwan, Adelheid Panzenboeck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trialE C Oldfield, W J Fessel, M W Dunne, et al.
Infection|October 6, 2025
Antimicrobial Stewardship in German non-university hospitals: baseline status and impact of a multifaceted AMS intervention within the prospective ID ROLL OUT studyR Giesen, G Först, G Fink, et al.
Genes & Development|January 19, 2005
Distinct functions of junD in cardiac hypertrophy and heart failureRomeo Ricci, Urs Eriksson, Gavin Y Oudit, et al.
Alzheimer'S Research & Therapy|April 16, 2015
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseHaakon B Nygaard, Allison F Wagner, Garrett S Bowen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2011
AKT kinase activity is required for lithium to modulate mood-related behaviors in miceJen Q Pan, Michael C Lewis, Josh K Ketterman, et al.
Pageof 134